[Pathogenetic bases of the therapy of chronic circulatory insufficiency].
D000042:Absorption; D001702:Biopharmaceutics; D001810:Blood Volume / Q000187:drug effects; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology*; D002908:Chronic Disease; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004074:Digitoxin / Q000097:blood; D004077:Digoxin / Q000097:blood; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004361:Drug Tolerance; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009318:Natriuresis / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000187:drug effects
D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D004232:Diuretics; D004077:Digoxin; D004074:Digitoxin
Patogeneticheskie osnovy terapii khronicheskoĭ nedostatochnosti krovoobrashcheniia